• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过构建基于人工智能的增强可重复性方法,识别反映精神分裂症病因的基因特征。

Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility.

机构信息

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.

School of Pharmaceutical Sciences, Chongqing University, Chongqing, China.

出版信息

CNS Neurosci Ther. 2019 Sep;25(9):1054-1063. doi: 10.1111/cns.13196. Epub 2019 Jul 27.

DOI:10.1111/cns.13196
PMID:31350824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6698965/
Abstract

AIMS

As one of the most fundamental questions in modern science, "what causes schizophrenia (SZ)" remains a profound mystery due to the absence of objective gene markers. The reproducibility of the gene signatures identified by independent studies is found to be extremely low due to the incapability of available feature selection methods and the lack of measurement on validating signatures' robustness. These irreproducible results have significantly limited our understanding of the etiology of SZ.

METHODS

In this study, a new feature selection strategy was developed, and a comprehensive analysis was then conducted to ensure a reliable signature discovery. Particularly, the new strategy (a) combined multiple randomized sampling with consensus scoring and (b) assessed gene ranking consistency among different datasets, and a comprehensive analysis among nine independent studies was conducted.

RESULTS

Based on a first-ever evaluation of methods' reproducibility that was cross-validated by nine independent studies, the newly developed strategy was found to be superior to the traditional ones. As a result, 33 genes were consistently identified from multiple datasets by the new strategy as differentially expressed, which might facilitate our understanding of the mechanism underlying the etiology of SZ.

CONCLUSION

A new strategy capable of enhancing the reproducibility of feature selection in current SZ research was successfully constructed and validated. A group of candidate genes identified in this study should be considered as great potential for revealing the etiology of SZ.

摘要

目的

作为现代科学中最基本的问题之一,“精神分裂症(SZ)的病因是什么”仍然是一个深刻的谜团,因为缺乏客观的基因标记。由于现有特征选择方法的能力不足以及缺乏对签名稳健性的测量,通过独立研究确定的基因特征的可重复性被发现非常低。这些不可复制的结果极大地限制了我们对 SZ 病因的理解。

方法

在这项研究中,开发了一种新的特征选择策略,然后进行了全面分析,以确保可靠的签名发现。特别是,新策略 (a) 将多次随机抽样与共识评分相结合,以及 (b) 评估不同数据集之间的基因排名一致性,并对九个独立研究进行了综合分析。

结果

基于对方法可重复性的首次评估,该评估通过九个独立研究进行了交叉验证,发现新开发的策略优于传统策略。结果,通过新策略从多个数据集一致鉴定出 33 个差异表达的基因,这可能有助于我们理解 SZ 病因的机制。

结论

成功构建并验证了一种能够提高当前 SZ 研究中特征选择可重复性的新策略。本研究中鉴定的一组候选基因应被视为揭示 SZ 病因的巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106b/6698965/76dd2152052a/CNS-25-1054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106b/6698965/1bf0fd40750e/CNS-25-1054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106b/6698965/76dd2152052a/CNS-25-1054-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106b/6698965/1bf0fd40750e/CNS-25-1054-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/106b/6698965/76dd2152052a/CNS-25-1054-g002.jpg

相似文献

1
Identification of the gene signature reflecting schizophrenia's etiology by constructing artificial intelligence-based method of enhanced reproducibility.通过构建基于人工智能的增强可重复性方法,识别反映精神分裂症病因的基因特征。
CNS Neurosci Ther. 2019 Sep;25(9):1054-1063. doi: 10.1111/cns.13196. Epub 2019 Jul 27.
2
Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data.通过综合转录组数据集的新型特征选择策略,确定精神分裂症的一致基因特征。
Brief Bioinform. 2020 May 21;21(3):1058-1068. doi: 10.1093/bib/bbz049.
3
Gene- and evidence-based candidate gene selection for schizophrenia and gene feature analysis.基于基因和证据的精神分裂症候选基因选择和基因特征分析。
Artif Intell Med. 2010 Feb-Mar;48(2-3):99-106. doi: 10.1016/j.artmed.2009.07.009. Epub 2009 Nov 26.
4
BDgene: a genetic database for bipolar disorder and its overlap with schizophrenia and major depressive disorder.BDgene:双相情感障碍及其与精神分裂症和重度抑郁症重叠的遗传数据库。
Biol Psychiatry. 2013 Nov 15;74(10):727-33. doi: 10.1016/j.biopsych.2013.04.016. Epub 2013 Jun 10.
5
The Correlation-Base-Selection Algorithm for Diagnostic Schizophrenia Based on Blood-Based Gene Expression Signatures.基于血液基因表达特征的精神分裂症诊断相关性基础选择算法
Biomed Res Int. 2017;2017:7860506. doi: 10.1155/2017/7860506. Epub 2017 Feb 9.
6
SZDB: A Database for Schizophrenia Genetic Research.SZDB:一个用于精神分裂症基因研究的数据库。
Schizophr Bull. 2017 Mar 1;43(2):459-471. doi: 10.1093/schbul/sbw102.
7
MS-ACGAN: A modified auxiliary classifier generative adversarial network for schizophrenia's samples augmentation based on microarray gene expression data.MS-ACGAN:一种基于微阵列基因表达数据的用于精神分裂症样本扩充的改良辅助分类器生成对抗网络。
Comput Biol Med. 2023 Aug;162:107024. doi: 10.1016/j.compbiomed.2023.107024. Epub 2023 May 26.
8
Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation.利用多重随机抽样的一致性评分和基因排名一致性评估推导稳定的微阵列癌症分化特征。
Cancer Res. 2007 Oct 15;67(20):9996-10003. doi: 10.1158/0008-5472.CAN-07-1601.
9
A GMM-IG framework for selecting genes as expression panel biomarkers.一种用于选择基因作为表达谱生物标志物的 GMM-IG 框架。
Artif Intell Med. 2010 Feb-Mar;48(2-3):75-82. doi: 10.1016/j.artmed.2009.07.006. Epub 2009 Dec 8.
10
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets.精神分裂症的外周生物标志物:微阵列基因表达数据集的荟萃分析。
Int J Neuropsychopharmacol. 2019 Mar 1;22(3):186-193. doi: 10.1093/ijnp/pyy103.

引用本文的文献

1
Multinomial machine learning identifies independent biomarkers by integrated metabolic analysis of acute coronary syndrome.多分类机器学习通过对急性冠脉综合征的代谢物综合分析鉴定独立的生物标志物。
Sci Rep. 2023 Nov 23;13(1):20535. doi: 10.1038/s41598-023-47783-5.
2
Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinoma.辐射敏感基因预后模型可识别头颈部鳞状细胞癌中具有辐射抗性风险的个体。
J Cancer Res Clin Oncol. 2023 Nov;149(17):15623-15640. doi: 10.1007/s00432-023-05304-x. Epub 2023 Sep 1.
3
Prediction of in-hospital hypokalemia using machine learning and first hospitalization day records in patients with traumatic brain injury.

本文引用的文献

1
Genome-wide identification and analysis of the eQTL lncRNAs in multiple sclerosis based on RNA-seq data.基于 RNA-seq 数据的多发性硬化症中的 eQTL lncRNAs 的全基因组鉴定和分析。
Brief Bioinform. 2020 May 21;21(3):1023-1037. doi: 10.1093/bib/bbz036.
2
A critical assessment of the feature selection methods used for biomarker discovery in current metaproteomics studies.当前代谢组学研究中用于生物标志物发现的特征选择方法的批判性评估。
Brief Bioinform. 2020 Jul 15;21(4):1378-1390. doi: 10.1093/bib/bbz061.
3
Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data.
基于机器学习和创伤性脑损伤患者首次住院日记录预测院内低钾血症。
CNS Neurosci Ther. 2023 Jan;29(1):181-191. doi: 10.1111/cns.13993. Epub 2022 Oct 18.
4
Identification of differentially expressed genes and their major pathways among the patient with COVID-19, cystic fibrosis, and chronic kidney disease.新型冠状病毒肺炎、囊性纤维化和慢性肾脏病患者中差异表达基因及其主要通路的鉴定。
Inform Med Unlocked. 2022;32:101038. doi: 10.1016/j.imu.2022.101038. Epub 2022 Aug 7.
5
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system.基于结构和配体的影响中枢神经系统药物发现中的人工智能和机器学习方法
Mol Divers. 2023 Apr;27(2):959-985. doi: 10.1007/s11030-022-10489-3. Epub 2022 Jul 11.
6
Construction of the Classification Model Using Key Genes Identified Between Benign and Malignant Thyroid Nodules From Comprehensive Transcriptomic Data.利用从综合转录组数据中鉴定出的甲状腺良恶性结节间的关键基因构建分类模型。
Front Genet. 2022 Jan 14;12:791349. doi: 10.3389/fgene.2021.791349. eCollection 2021.
7
VARIDT 2.0: structural variability of drug transporter.VARIDT 2.0:药物转运体的结构变异性。
Nucleic Acids Res. 2022 Jan 7;50(D1):D1417-D1431. doi: 10.1093/nar/gkab1013.
8
The miRNA: a small but powerful RNA for COVID-19.miRNA:COVID-19 中的一种小而强大的 RNA。
Brief Bioinform. 2021 Mar 22;22(2):1137-1149. doi: 10.1093/bib/bbab062.
9
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.人工智能和机器学习辅助中枢神经系统疾病药物发现:现状与未来方向。
Med Res Rev. 2021 May;41(3):1427-1473. doi: 10.1002/med.21764. Epub 2020 Dec 9.
10
A Method for Identifying Vesicle Transport Proteins Based on LibSVM and MRMD.基于 LibSVM 和 MRMD 的囊泡运输蛋白鉴定方法
Comput Math Methods Med. 2020 Oct 19;2020:8926750. doi: 10.1155/2020/8926750. eCollection 2020.
通过综合转录组数据集的新型特征选择策略,确定精神分裂症的一致基因特征。
Brief Bioinform. 2020 May 21;21(3):1058-1068. doi: 10.1093/bib/bbz049.
4
Simultaneous Improvement in the Precision, Accuracy, and Robustness of Label-free Proteome Quantification by Optimizing Data Manipulation Chains.通过优化数据处理链,同时提高无标记蛋白质组定量的精密度、准确性和稳健性。
Mol Cell Proteomics. 2019 Aug;18(8):1683-1699. doi: 10.1074/mcp.RA118.001169. Epub 2019 May 16.
5
The Effect of Mind-Body Therapies on Insomnia: A Systematic Review and Meta-Analysis.身心疗法对失眠的影响:一项系统评价与荟萃分析。
Evid Based Complement Alternat Med. 2019 Feb 13;2019:9359807. doi: 10.1155/2019/9359807. eCollection 2019.
6
The three-dimensional landscape of the genome in human brain tissue unveils regulatory mechanisms leading to schizophrenia risk.人类脑组织中基因组的三维景观揭示了导致精神分裂症风险的调控机制。
Schizophr Res. 2020 Mar;217:17-25. doi: 10.1016/j.schres.2019.03.007. Epub 2019 Mar 18.
7
Polygenic Risk Scores in Clinical Schizophrenia Research.临床精神分裂症研究中的多基因风险评分
Am J Psychiatry. 2019 Jan 1;176(1):3-4. doi: 10.1176/appi.ajp.2018.18111274.
8
Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics.评估直接数据合并策略在长期和大规模药物代谢组学中的有效性。
Front Pharmacol. 2019 Feb 20;10:127. doi: 10.3389/fphar.2019.00127. eCollection 2019.
9
Leveraging brain cortex-derived molecular data to elucidate epigenetic and transcriptomic drivers of complex traits and disease.利用大脑皮层衍生的分子数据阐明复杂特征和疾病的表观遗传和转录组驱动因素。
Transl Psychiatry. 2019 Feb 28;9(1):105. doi: 10.1038/s41398-019-0437-2.
10
Microglia, complement and schizophrenia.小胶质细胞、补体与精神分裂症。
Nat Neurosci. 2019 Mar;22(3):333-334. doi: 10.1038/s41593-019-0343-1.